US Patent Issued to Avails Medical on July 8 for "Devices, systems and methods to detect the presence of B-lactam antibiotic hydrolyzing bacteria in a sample" (California Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,352,714, issued on July 8, was assigned to Avails Medical Inc. (Menlo Park, Calif.).

"Devices, systems and methods to detect the presence of B-lactam antibiotic hydrolyzing bacteria in a sample" was invented by Meike Herget (Woodside, Calif.), Oren S. Knopfmacher (San Francisco) and Michael D. Laufer (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various devices, systems and methods for detecting the presence of Beta-lactam antibiotic hydrolyzing bacteria in a sample are disclosed. In one embodiment, a method of detecting the presence of Beta-lactam antibiotic hydrolyzing bacteria includes introducing the sample to a filter configured...